COVID-19 early curative treatments in kidney transplant recipients: is it really reasonable at the Omicron era?
Description
CONCLUSIONS: There was no difference in outcome according to early therapeutic management: n/r, sotrovimab or no specific treatment. Our study both underlines a decreased severity of Omicron COVID-19 in KTRs (probably related to vaccinal immunity and
